Sector ratings Akeso, Inc.

Equities

Market Closed - Hong Kong S.E. Other stock markets 01:38:08 15/04/2026 pm IST			5-day change	1st Jan Change
147.40 ^HKD	+6.89%		+7.20%	+30.44%

07/04	Akeso Presents Updated Data on Cadonilimab Combination Therapy in PD-(L)1 Inhibitor-Resistant Advanced NSCLC at ELCC 2026	CI
31/03	Akeso, Inc. Announces the Results of Health-Related Quality of Life Data from the HARMONi-2 Study At the 2026 European Lung Cancer Congress	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation	Visibility
AKESO, INC.	1.62TCr		B		-
ARGENX SE	5.17TCr		A
WUXI APPTEC CO., LTD.	4.71TCr		AAA
INSMED INCORPORATED	3.31TCr	-	A	-	-
BIONTECH SE	2.49TCr	-	-	-	-
WUXI BIOLOGICS (CAYMAN) INC.	1.97TCr		AAA
GENMAB A/S	1.79TCr		A
SUMMIT THERAPEUTICS INC.	1.62TCr	-	-	-	-
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1.44TCr	-	AA	-	-
MADRIGAL PHARMACEUTICALS, INC.	1.2TCr	-	B	-	-
EXELIXIS, INC.	1.19TCr		BB
REMEGEN CO., LTD.	1.02TCr		-
ARROWHEAD PHARMACEUTICALS, INC.	933.87Cr	-	BB	-	-
SAMSUNG EPIS HOLDINGS CO., LTD.	914.01Cr		-			-
VAXCYTE, INC.	903.24Cr	-	BBB	-	-
NUVALENT, INC.	825.64Cr	-	CCC	-	-
CYTOKINETICS, INCORPORATED	817.19Cr	-	AA	-	-
IMMUNITYBIO, INC.	784.87Cr	-	CCC	-	-
PHARMAESSENTIA CORPORATION	754.66Cr		AA
BELITE BIO, INC	676.37Cr	-	-	-	-
Average	1.71TCr		A
Weighted average by Cap.			A